Rapport Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $297k | 10k | 29.70 |
| 2025-03-31 | $106k | 11k | 10.03 |
| 2024-12-31 | $127k | 7.2k | 17.74 |
| 2024-09-30 | $83k | 4.0k | 20.48 |